The 1 analysts offering 12-month price forecasts for XBiotech Inc have a median target of 18.00, with a high estimate of 18.00 and a low estimate of 18.00. The median estimate represents a +45.16% increase from the last price of 12.40.
The current consensus among 1 polled investment analysts is to Buy stock in XBiotech Inc. This rating has held steady since June, when it was upgraded from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.06
Reporting Date May 13
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.